Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 3/20 | 0.43 |
| ▸ | RORC | P51449 | 1/20 | 0.43 |
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.41 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12596935 | 0.94 | HCAR3 (0.40) | KDM4EALDH1A1HPGDPTGER4MAPT | |
| SCHEMBL13640244 | 0.89 | HCAR3 (0.38) | KDM4EALDH1A1HPGDPTGER4MAPT | |
| SCHEMBL18807617 | 0.89 | HCAR3 (0.38) | KDM4EALDH1A1HPGDPTGER4MAPT | |
| SCHEMBL27867364 | 0.85 | KDM4E (0.52) | KDM4EALDH1A1HPGDPTGER4MAPT | |
| SCHEMBL21636235 | 0.83 | KDM4E (0.61) | KDM4EALDH1A1HPGDPTGER4MAPT | |
| SCHEMBL6312041 | 0.81 | RECQL (0.49) | KDM4EALDH1A1HPGDPTGER4MAPT | |
| SCHEMBL4728742 | 0.78 | PTGER4 (0.62) | KDM4EALDH1A1HPGDPTGER4MAPT | |
| SCHEMBL1979651 | 0.77 | ALDH1A1 (0.47) | KDM4EALDH1A1HPGDMAPTMAPK1 | |
| SCHEMBL18807711 | 0.76 | CNR2 (0.41) | KDM4EALDH1A1HPGDMAPTMAPK1 | |
| SCHEMBL4727898 | 0.76 | PTGER4 (0.53) | KDM4EALDH1A1HPGDPTGER4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2509948-B1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA GRAPHICS NV (BE) | 2017-05-03 | — | — | EP | disclosed |
| EP-2509948-B1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA GRAPHICS NV (BE) | 2017-05-03 | — | — | EP | disclosed |
| EP-2510400-B1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA GRAPHICS NV (BE) | 2015-04-29 | — | — | EP | disclosed |
| US-8957224-B2 | Photoinitiators for UV-LED curable compositions and inks | AGFA GRAPHICS NV (BE) | 2015-02-17 | — | — | US | disclosed |
| US-8957224-B2 | Photoinitiators for UV-LED curable compositions and inks | AGFA GRAPHICS NV (BE) | 2015-02-17 | — | — | US | disclosed |
| US-8957224-B2 | Photoinitiators for UV-LED curable compositions and inks | AGFA GRAPHICS NV (BE) | 2015-02-17 | — | — | US | disclosed |
| US-8569393-B2 | UV-LED curable compositions and inks | AGFA-GEVAERT N.V. (BE) | 2013-10-29 | — | — | US | disclosed |
| US-8569393-B2 | UV-LED curable compositions and inks | AGFA-GEVAERT N.V. (BE) | 2013-10-29 | — | — | US | disclosed |
| US-8569393-B2 | UV-LED curable compositions and inks | AGFA-GEVAERT N.V. (BE) | 2013-10-29 | — | — | US | disclosed |
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-12-06 | — | — | US | disclosed |
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-12-06 | — | — | US | disclosed |
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-12-06 | — | — | US | disclosed |
| US-20120283349-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-11-08 | — | — | US | disclosed |
| US-20120283349-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-11-08 | — | — | US | disclosed |
| US-20120283349-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-11-08 | — | — | US | disclosed |
| EP-2510400-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | Agfa-Gevaert (BE) | 2012-10-17 | — | — | EP | disclosed |
| EP-2509948-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | Agfa-Gevaert (BE) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011069947-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT (BE) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011069943-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT (BE) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011069943-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT (BE) | 2011-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | WEE1, CBX4, USP9X | KDM4E 1156/4885ALDH1A1 1029/4885HPGD 3146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.